The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) Enhances the Radiation Responsiveness of Lung and Colorectal Tumor Xenografts
Shannon, Aoife M, Telfer, Brian A, Smith, Paul D, Babur, Muhammed, Logie, Armelle, Wilkinson, Robert W, Debray, Camille, Stratford, Ian J, Williams, Kaye J, Wedge, Stephen R
Published in Clinical cancer research (01.11.2009)
Published in Clinical cancer research (01.11.2009)
Get full text
Journal Article
The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but does not enhance the efficacy of doxorubicin, despite improving tumor perfusion and radiation response in mice
Ali, Majid, Kamjoo, Marzieh, Thomas, Huw D, Kyle, Suzanne, Pavlovska, Ivanda, Babur, Muhammed, Telfer, Brian A, Curtin, Nicola J, Williams, Kaye J
Published in Molecular cancer therapeutics (01.12.2011)
Published in Molecular cancer therapeutics (01.12.2011)
Get full text
Journal Article
The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but doesn’t enhance the efficacy of doxorubicin, despite improving tumour perfusion and radiation response in mice
Ali, Majid, Kamjoo, Marzieh, Thomas, Huw D, Kyle, Suzanne, Pavlovska, Ivanda, Babur, Muhammed, Telfer, Brian A, Curtin, Nicola J, Williams, Kaye J
Published in Molecular cancer therapeutics (16.09.2011)
Published in Molecular cancer therapeutics (16.09.2011)
Get full text
Journal Article